Clinical effect of BACE combined with I~(125) seed in the treatment of patients with advanced lung cancer
XU Ren-lian
Abstract
XU Ren-lian
Abstract
Objective To observe the clinical effect of bronchial artery occlusion induced by BACE combined with I125 seed implantation in the treatment of advanced lung cancer. Methods 39 cases of bronchial artery occlusion after BACE treatment were selected,and they were implanted with I125 seed again in 30 days under CT guided percutaneous. Another 41 cases of BACE were treated as the control group. Results There were 17 cases of CR,19 cases of PR,and 3 cases of NC in the study group. The total response rate( CR + PR) was 92. 3% in the study group. The 3-month survival rate was 94. 2%,the 6-month survival rate was 91. 3%,and the 1-year survival rate was 83. 2% in the study group. There were 12 cases of CR,21 cases of PR,and 8 cases of NC in the control group. The total response rate( CR + PR) was 80. 4% in the control group. The 3-month survival rate was 93. 1%,the 6-month survival rate was 88. 4%,and the 1-year survival rate was 72. 6% in the control group. Conclusion BACE combined with I125 seed implantation under CT guided percutaneous is minimally invasive safe and shows higher total effective rate in the treatment of advanced lung cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the clinical effect of bronchial artery occlusion induced by BACE combined with I125 seed implantation in the treatment of advanced lung cancer. Methods 39 cases of bronchial artery occlusion after BACE treatment were selected,and they were implanted with I125 seed again in 30 days under CT guided percutaneous. Another 41 cases of BACE were treated as the control group. Results There were 17 cases of CR,19 cases of PR,and 3 cases of NC in the study group. The total response rate( CR + PR) was 92. 3% in the study group. The 3-month survival rate was 94. 2%,the 6-month survival rate was 91. 3%,and the 1-year survival rate was 83. 2% in the study group. There were 12 cases of CR,21 cases of PR,and 8 cases of NC in the control group. The total response rate( CR + PR) was 80. 4% in the control group. The 3-month survival rate was 93. 1%,the 6-month survival rate was 88. 4%,and the 1-year survival rate was 72. 6% in the control group. Conclusion BACE combined with I125 seed implantation under CT guided percutaneous is minimally invasive safe and shows higher total effective rate in the treatment of advanced lung cancer.
Key concepts: Medicine, Survival rate, Lung cancer, Percutaneous, Occlusion, Surgery, Urology, Internal medicine